š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
Evaluate the safety and efficacy of Siponimod (BAF312) versus placebo in a ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-20
Trial ID
NCT01665144
The primary goal of this study is to assess the impact of the two major dis...
Status
Completed
Location
Brigham MS Center
Start Date
2021-06-01
Trial ID
NCT05060354
Treatments Being Tested
This study will utilize a prospective, observational, exposure cohort desig...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2021-12-15
Trial ID
NCT04933552
Treatments Being Tested
to quantify the effect of different degrees of renal impairment on the phar...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-07
Trial ID
NCT01904214
Treatments Being Tested
To assess the efficacy of Mayzent on microglia pathology in patients with a...
Status
Terminated
Location
University at Buffalo, Buffalo General Hospital
Start Date
2021-11-13
Trial ID
NCT04925557
This was a retrospective cohort study utilizing secondary data from IQVIA's...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-12-03
Trial ID
NCT05576779
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and effect...
Status
Completed
Location
Novartis
Start Date
2006-10
Trial ID
NCT00422175
Treatments Being Tested
The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Start Date
2019-01-03
Trial ID
NCT03535298
Treatments Being Tested
To assess safety and tolerability of patients converting from approved Rela...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-02-14
Trial ID
NCT03623243
Treatments Being Tested